J. S. Valencia Quintero and D. Castillo, “Venglustat, Lanreotide Acetate, and Tolvaptan as therapeutic options for the treatment of autosomic dominant polychistic kidney disease: a narrative review”, Interdiscip J Epidemiol Pub Health, vol. 3, no. 2, p. e7246, Dec. 2020, doi: 10.18041/2665-427X/ijeph.2.7246.